The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study

Hirofumi Akita(The University of Osaka), Masato Sakon(Osaka University), Masayuki Ohue(Hyogo Medical University), Hiroshi Wada, Yuko Soh(Osaka International Cancer Institute), Hiroshi Miyata(Osaka University), Ayano Kagawa(Osaka International Cancer Institute), Yoshitomo Yanagimoto(Osaka International Cancer Institute), Akira Tomokuni(Apple (Israel)), Kazuyoshi Yamamoto(Osaka International Cancer Institute), Satoko Marukawa(Osaka International Cancer Institute), Ayami Ochi(Osaka International Cancer Institute), Junichi Nishimura, Hidenori Takahashi(Osaka International Cancer Institute), Keijiro Sugimura(Osaka International Cancer Institute), Masayoshi Yasui(Osaka International Cancer Institute), Yusuke Takahashi(Sysmex (Japan)), Takeshi Omori(Osaka International Cancer Institute), Yuko Taniguchi(Nagase ChemteX (Japan)), Masahiko Yano(Nagoya Sangyo University), Tomoyuki Yamasaki(Osaka International Cancer Institute), Kei Asukai(Osaka International Cancer Institute)

Clinical Nutrition ESPEN

June 21, 2019

Cited by 56

|NEJM Evidence|2022|1.1k

|Journal of Biological Chemistry|2003|347

|Journal of Surgical Oncology|2009|333

|Annals of Surgery|2005|265

|Retrovirology|2005|199

Related Papers